Russia's AI-Driven Personalized Cancer Vaccine Program Shows Promising Early Results
AI becomes ‘powerful weapon’ against cancer in Russia’s custom vaccine push (VIDEO)
Image: Rt
Russia's personalized cancer vaccine program, utilizing artificial intelligence, has begun treating over 40 patients, showing a significant increase in key antibodies. The treatment customizes vaccines based on individual tumor characteristics, aiming to enhance immune response against cancer cells while preserving healthy tissue.
- 01The program has treated over 40 patients, with initial results showing a 50- to 100-fold increase in key antibodies.
- 02The vaccine is tailored for each patient using AI to identify unique tumor mutations from their genetic material.
- 03The first two colorectal cancer patients have received five injections, with observed decreases in lymph node size.
- 04The treatment process takes approximately 42 days, involving tumor and blood analysis followed by vaccine development.
- 05Clinical effectiveness will be evaluated after three months through MRI scans to assess changes in lymph nodes and metastatic sites.
Advertisement
In-Article Ad
Russia's personalized cancer vaccine initiative, spearheaded by the Russian Federal Medical-Biological Agency and led by former Health Minister Veronika Skvortsova, has enrolled over 40 patients. The program employs artificial intelligence to develop custom vaccines that target specific mutations in patients' tumors. This innovative approach has already demonstrated a 50- to 100-fold increase in key antibodies in initial patients. The treatment process, which lasts about 42 days, involves sequencing RNA from tumor and blood samples to identify unique cancer markers. Following this, the vaccine introduces peptides that help the immune system recognize and attack malignant cells while preserving healthy tissue. Early results from two colorectal cancer patients indicate a reduction in lymph node size after five injections. However, Skvortsova cautioned that it is premature to declare clinical effectiveness, with a significant evaluation set for three months post-treatment.
Advertisement
In-Article Ad
The program aims to improve cancer treatment outcomes in Russia, potentially leading to more effective therapies for patients.
Advertisement
In-Article Ad
Reader Poll
What do you think about the use of AI in cancer treatment?
Connecting to poll...
Read the original article
Visit the source for the complete story.